APOE and Alzheimer disease: Polymorphism in the allele 4 of ApoE (ApoE-e4), for example, appears in about 40–65% of the individuals diagnosed with AD and it is related to the unbalance in Aβ clearance, leading to its accumulation and aggregation (Long and Holtzman, 2019; Yamazaki et al., 2019).